| /report/000138550823000073-ruth-matthew-r-2023-03-02 |
OPIANT PHARMACEUTICALS, INC. |
02 Mar 2023 |
5 |
-$638,320 |
4 |
Chief Commercial Officer |
03 Mar 2023, 08:22 |
| /report/000138550822000114-ruth-matthew-r-2022-07-20 |
OPIANT PHARMACEUTICALS, INC. |
20 Jul 2022 |
1 |
-$11,512 |
4 |
Chief Commercial Officer |
21 Jul 2022, 16:08 |
| /report/000138550822000099-ruth-matthew-r-2022-06-27 |
OPIANT PHARMACEUTICALS, INC. |
27 Jun 2022 |
1 |
$0 |
4 |
Chief Commercial Officer |
29 Jun 2022, 16:01 |
| /report/000138550822000009-ruth-matthew-r-2022-01-04 |
OPIANT PHARMACEUTICALS, INC. |
04 Jan 2022 |
1 |
$0 |
4 |
Chief Commercial Officer |
05 Jan 2022, 15:16 |
| /report/000138550821000121-ruth-matthew-r-2021-08-31 |
OPIANT PHARMACEUTICALS, INC. |
31 Aug 2021 |
1 |
+$34,680 |
4 |
Chief Commercial Officer |
01 Sep 2021, 16:04 |
| /report/000138550821000096-ruth-matthew-r-2021-07-19 |
OPIANT PHARMACEUTICALS, INC. |
19 Jul 2021 |
2 |
$0 |
4 |
Chief Commercial Officer |
20 Jul 2021, 16:09 |
| /report/000138550821000095-ruth-matthew-r-2021-07-19 |
OPIANT PHARMACEUTICALS, INC. |
19 Jul 2021 |
0 |
$0 |
3 |
Chief Commercial Officer |
20 Jul 2021, 16:08 |